Výsledky vyhledávání - D G Kieback

  • Zobrazuji výsledky 1 - 6 z 6
Upřesnit hledání
  1. 1
    A germline TaqI restriction fragment length polymorphism in the progesterone receptor gene in ovarian carcinoma

    A germline TaqI restriction fragment length polymorphism in the progesterone receptor gene in ovarian carcinoma Autor Neil J. McKenna, D G Kieback, D. N. Carney, M. D. Fanning, James H. McLinden, Denis R. Headon

    Vydáno 1995
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  2. 2
    Effects of exemestane and tamoxifen on bone health within the Tamoxifen Exemestane Adjuvant Multicentre (TEAM) trial: results of a German, 12-month, prospective, randomised substudy

    Effects of exemestane and tamoxifen on bone health within the Tamoxifen Exemestane Adjuvant Multicentre (TEAM) trial: results of a German, 12-month, prospective, randomised substud... Autor Peyman Hadji, M. Ziller, D. G. Kieback, W. Dornoff, H.W. Tessen, Thomas Menschik, Joachim Kuck, F. Melchert, Annette Hasenburg

    Vydáno 2009
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  3. 3
    Multicenter phase II study of oral capecitabine (Xeloda“) in patients with metastatic breast cancer relapsing after treatment with a taxane-containing therapy

    Multicenter phase II study of oral capecitabine (Xeloda“) in patients with metastatic breast cancer relapsing after treatment with a taxane-containing therapy Autor Peter Reichardt, Gϋnter von Minckwitz, Peter Thuss‐Patience, W. Jonat, H Kölbl, F. Jänicke, D G Kieback, W. Kühn, A. E. Schindler, Svjetlana Mohrmann, M. Kaufmann, Hans‐Joachim Lück

    Vydáno 2003
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  4. 4
    Reduced cardiotoxicity and comparable efficacy in a phase IIItrial of pegylated liposomal doxorubicin HCl(CAELYX™/Doxil®) versus conventional doxorubicin forfirst-line treatment of metastatic breast cancer

    Reduced cardiotoxicity and comparable efficacy in a phase IIItrial of pegylated liposomal doxorubicin HCl(CAELYX™/Doxil®) versus conventional doxorubicin forfirst-line treatment of... Autor E O’Brien, Nely Wigler, Moshe Inbar, R. Rosso, Eva‐Maria Grischke, Armando Santoro, Raphael Catane, D G Kieback, Piotr Tomczak, Stephen P. Ackland, F. Orlandi, L. Mellars, Leila Alland, Craig Tendler

    Vydáno 2004
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  5. 5
    Mammostrat As an Immunohistochemical Multigene Assay for Prediction of Early Relapse Risk in the Tamoxifen Versus Exemestane Adjuvant Multicenter Trial Pathology Study

    Mammostrat As an Immunohistochemical Multigene Assay for Prediction of Early Relapse Risk in the Tamoxifen Versus Exemestane Adjuvant Multicenter Trial Pathology Study Autor John M.S. Bartlett, Kenneth J. Bloom, Tammy Piper, Thomas J. Lawton, Cornelis J.�H. van de Velde, Douglas T. Ross, Brian Z. Ring, Robert S. Seitz, Rodney A. Beck, Annette Hasenburg, D. G. Kieback, Hein Putter, Christos Markopoulos, Luc Dirix, Caroline Seynaeve, Daniel Rea

    Vydáno 2012
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  6. 6
    Estrogen Receptor and Progesterone Receptor As Predictive Biomarkers of Response to Endocrine Therapy: A Prospectively Powered Pathology Study in the Tamoxifen and Exemestane Adjuvant Multinational Trial

    Estrogen Receptor and Progesterone Receptor As Predictive Biomarkers of Response to Endocrine Therapy: A Prospectively Powered Pathology Study in the Tamoxifen and Exemestane Adjuv... Autor John M.S. Bartlett, Cassandra Brookes, Tammy Robson, Cornelis J.�H. van de Velde, Lucinda Billingham, Fiona Campbell, Margaret Grant, Annette Hasenburg, E.T.M. Hille, Charlene Kay, D. G. Kieback, Hein Putter, Christos Markopoulos, Elma Meershoek‐Klein Kranenbarg, Elizabeth A. Mallon, Luc Dirix, Caroline Seynaeve, Daniel Rea

    Vydáno 2011
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:

Vyhledávací nástroje: